期刊文献+

临床药师对2型糖尿病患者使用甲泼尼龙引起高血糖的药学监护 被引量:2

Pharmacological Care for Hyperglycemia Induced by Methylprednisolone in Patients with Type 2 Diabetes by Clinical Pharmacists
下载PDF
导出
摘要 目的:探讨药师参与2型糖尿病患者使用甲泼尼龙引起高血糖的治疗方案与药学监护方法。方法:临床药师参与1例2型糖尿病患者使用注射用甲泼尼龙琥珀酸钠抗炎治疗诱发高血糖的处理,分析治疗方案并提出建议,提供药学服务。结果:临床药师调整降血糖的用药方案被医师采纳,患者血糖稳定后出院。结论:临床药师能协助医师制订安全、有效的治疗方案,给患者提供良好的药学服务。 OBJECTIVE: To probe into the treatment regimen and methods of pharmacological care for hyperglycemia induced by methylprednisolone in patients with type 2 diabetes participated by clinical pharmacists.METHODS: Clinical pharmacists participated into the treatment of hyperglycemia induced by anti-inflammatory treatment with injection of methylprednisolone sodium succinate in a patient with type 2 diabetes. The treatment regimen was analyzed and recommendations were made to provide pharmacological care. RESULTS: The treatment regimen formulated by the clinical pharmacists to regulate the hypoglycemia was adopted by the physicians,and patients were discharged after the blood glucose was stable. CONCLUSIONS: Clinical pharmacists can assist the physicians in formulating safe and effective treatment options and provide patients with better pharmaceutical care and medication education.
作者 姜丽红 廉超 JIANG Lihong;LIAN Chao(Dept.of Pharmacy,Shandong Academy of Medical Sciences/Shandong Institute of Ophthalmology/Shandong Eye Hospital,Shandong Jinan 250021,China)
出处 《中国医院用药评价与分析》 2018年第9期1292-1293,1296,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 甲泼尼龙琥珀酸钠 糖皮质激素 胰岛素 高血糖 药学监护 Methylprednisolone Sodium Succinate Glucocorticoid Insulin Hyperglycemia Pharmaceutical care
  • 相关文献

参考文献5

二级参考文献84

  • 1Donihi AC, Raval D corticosteroid-related Saul M, et al. Prevalence and predictors of hyperglycemia in hospitalized patients [ J ]Endocr Pratt, 2006,12:358-362.
  • 2A rnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement [ J ]. J Clin Endocrinol Metab, 2003,88:5593-5602.
  • 3Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control [ J ]. Diabetes Care, 2009,32 : 1119-1131.
  • 4Jamieson PM, Nyirenda M J, Walker BR, et al. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes; possible evidence for a role of hepatic l ll3-hydroxysteroid dehydrogenase type 1 [ J ]. J Endocrinol, 1999, 160 : 103-109.
  • 5Djurhuus CB, Gravhoh CH, Nielsen S, et al. Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans [ J ]. Am J Physiol Endocrinol Metab, 2002,283 : E172-E177.
  • 6Krsek M, Rosicka M, Nedvidkova J, et al. Increased lipolysis of subcutaneous abdominal adipose tissue and altered no-radrenergic activity in patients with Cushing's syndrome: an in- vivo microdialysis study [ J ]. Physiol Res, 2006,55 : 421-428.
  • 7Volgi JR, Baldwin D Jr. Glucocortieoid therapy and diabetes management[ J]. Nuts Clin North Am, 2001,36:333-339.
  • 8Gathereole LL, Bujalska IJ, Stewart PM, et al. Glucocorticoid modulation of insulin signaling in human subcutaneous adipose tissue [ J]. J Clin Endocrinol Metab, 2007,92:43324339.
  • 9Lundgren M, Buren J, Ruge T, et al. Glucocortieoids downregulate glucose uptake capacity and insulin-signaling proteins in mental but not subcutaneous human adipoeytes [ J ]. J Clin Endocrinol Metab, 2004, 89,2989-2997.
  • 10Iwamoto T, Kagawa Y, Naito Y, et al. Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases [ J]. Pharmacotherapy, 2004,24:508-514.

同被引文献7

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部